FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to pharmacology and pharmacy, and refers to pharmaceutical composition for treating of cerebrovascular disorders. Composition contains active substance of 1-Hydroxy-4-adamantanone and pharmaceutically acceptable target additives applicable in liquid dosage forms, selected from auxiliary substances of solvents group in certain proportions of said components. Composition is presented in the form of solution for injections, solution for infusions and contains optimal quantity of auxiliary substances. Dosage forms based on pharmaceutical compositions meet all requirements of XII edition of State Pharmacopeia.
EFFECT: cerebrovascular disorders treatment.
7 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
| INJECTABLE DOSAGE FORM FOR TREATMENT OF PARKINSON'S DISEASE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2520758C2 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| INJECTION DOSAGE FORM FOR ACUTE STROKE TREATMENT, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2005 |
|
RU2330680C2 |
| PHARMACEUTICAL FORMULATION FOR TREATING DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION | 2012 |
|
RU2504375C1 |
| MEANS FOR ISCHEMIA TREATMENT, METHOD FOR ITS PRODUCTION AND METHOD FOR ISCHEMIA TREATMENT (VERSIONS) | 2015 |
|
RU2620163C2 |
| AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND USING THEM IN TREATING CEREBROVASCULAR DISORDERS | 2012 |
|
RU2516922C2 |
